HECTD1 Antikörper
-
- Target Alle HECTD1 Antikörper anzeigen
- HECTD1 (HECT Domain Containing 1 (HECTD1))
-
Reaktivität
- Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser HECTD1 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC), Immunofluorescence (IF)
- Kreuzreaktivität
- Ratte
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant protein corresponding to Mouse HECTD1
- Top Product
- Discover our top product HECTD1 Primärantikörper
-
anti-HECT Domain Containing 1 (HECTD1) (AA 3-110) antibody
HECTD1 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 1E10 unconjugated
anti-HECT Domain Containing 1 (HECTD1) antibodyHECTD1 Reaktivität: Human, Maus, Ratte WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-HECT Domain Containing 1 (HECTD1) (AA 3-110) antibodyHECTD1 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-HECT Domain Containing 1 (HECTD1) antibodyHECTD1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-HECT Domain Containing 1 (HECTD1) (AA 3-110) antibodyHECTD1 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 1C7 unconjugated
anti-HECT Domain Containing 1 (HECTD1) (AA 2518-2610) antibodyHECTD1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-HECT Domain Containing 1 (HECTD1) (AA 1-50) antibodyHECTD1 Reaktivität: Human, Maus, Ratte, Xenopus laevis, Zebrafisch (Danio rerio), Huhn, Hund WB, IHC, IP, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- IHC/IF (R) 1:1000-1:2000/1:1000-1:2000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS, pH 7.4, 0.02 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
-
- Target
- HECTD1 (HECT Domain Containing 1 (HECTD1))
- Andere Bezeichnung
- HECTD1 (HECTD1 Produkte)
- Hintergrund
- HECTD1 (E3 ubiquitin-protein ligase, which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates . Mediates 'Lys-63'-linked polyubiquitination of HSP90AA1 which leads to its intracellular localization and reduced secretion . Negatively regulating HSP90AA1 secretion in cranial mesenchyme cells impairs their emigration and is consequently essential for the correct development of the cranial neural folds and neural tube closure.It is also involved in sporadic Parkinson's disease.
- UniProt
- Q69ZR2
- Pathways
- Tube Formation, SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion
-
